Source: Citybizlist

Trials.ai: ZS to Acquire Trials.ai

EVANSTON, Ill.-(BUSINESS WIRE)-Global management consulting and technology firm ZS announced today it has entered into a definitive agreement to acquire... Read MoreThe post ZS to Acquire Trials.ai appeared first on citybiz.

Read full article »

Trials.ai's Competitors | Trials.ai's News | Trials.ai's Financials

Followers on Owler

180

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

Co-Founder & CEO

Kim Padilla Walpole

CEO Approval Rating

90/100

Trials.ai is a California-based AI-powered platform that offers solutions such as clinical trials, protocol design, and decision support for the healthcare sector.